Amy H Farabaugh

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. pmc Cognitive therapy for anxious depression in STAR(*) D: what have we learned?
    Amy Farabaugh
    Depression Clinical and Research Program, Massachusetts General Hospital, United States
    J Affect Disord 142:213-8. 2012
  2. doi request reprint Depression and suicidal ideation in college students
    Amy Farabaugh
    Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA 02114, USA
    Psychopathology 45:228-34. 2012
  3. doi request reprint Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder
    Amy Farabaugh
    Depression Clinical and Research Program, Department of Neurology, Massachusetts General Hospital, 15 Parkman St, WAC 812, Boston, MA 02114, USA
    Psychosomatics 51:124-9. 2010
  4. ncbi request reprint Dysfunctional attitudes and personality disorder comorbidity during long-term treatment of MDD
    Amy Farabaugh
    Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Depress Anxiety 24:433-9. 2007
  5. ncbi request reprint Differences in cognitive factors between "true drug" versus "placebo pattern" response to fluoxetine as defined by pattern analysis
    Amy H Farabaugh
    Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, USA USA
    Hum Psychopharmacol 21:221-5. 2006
  6. pmc Assessing depression and factors possibly associated with depression during the course of Parkinson's disease
    Amy H Farabaugh
    Depression Clinical and Research Program, Massachusetts General Hospital, 1 Bowdoin Square, Boston, MA 02114, USA
    Ann Clin Psychiatry 23:171-7. 2011
  7. ncbi request reprint Predictors of stable personality disorder diagnoses in outpatients with remitted depression
    Amy Farabaugh
    Depression and Clinical Research Program, Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA
    J Nerv Ment Dis 190:248-56. 2002
  8. ncbi request reprint Relationships between major depressive disorder and comorbid anxiety and personality disorders
    Amy Farabaugh
    Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Compr Psychiatry 46:266-71. 2005
  9. pmc Pattern of depressive symptoms in Parkinson's disease
    Amy H Farabaugh
    Massachusetts General Hospital, Boston, MA 02114, USA
    Psychosomatics 50:448-54. 2009
  10. ncbi request reprint The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients
    Amy Farabaugh
    Depression Clinical and Research Program, Massachusetts General Hospital, MA WAC 812, USA
    Int Clin Psychopharmacol 20:87-91. 2005

Research Grants

Detail Information

Publications36

  1. pmc Cognitive therapy for anxious depression in STAR(*) D: what have we learned?
    Amy Farabaugh
    Depression Clinical and Research Program, Massachusetts General Hospital, United States
    J Affect Disord 142:213-8. 2012
    ..The primary aim of this study was to assess the effectiveness of cognitive therapy (CT) alone or in combination with medications for anxious versus non-anxious depression...
  2. doi request reprint Depression and suicidal ideation in college students
    Amy Farabaugh
    Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA 02114, USA
    Psychopathology 45:228-34. 2012
    ..Suicide is one of the leading causes of death in college students and is often associated with depression. The aim of this study was to assess the rates of suicidal ideation (SI) on college campuses and to identify its correlates...
  3. doi request reprint Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder
    Amy Farabaugh
    Depression Clinical and Research Program, Department of Neurology, Massachusetts General Hospital, 15 Parkman St, WAC 812, Boston, MA 02114, USA
    Psychosomatics 51:124-9. 2010
    ..Depression has been recognized as a common feature of Parkinson's disease (PD), and is the most prevalent psychiatric disorder in PD patients...
  4. ncbi request reprint Dysfunctional attitudes and personality disorder comorbidity during long-term treatment of MDD
    Amy Farabaugh
    Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Depress Anxiety 24:433-9. 2007
    ..This finding suggests that dysfunctional attitudes that persist beyond remission of MDD may be a marker for certain personality disorders that are stable across long-term treatment...
  5. ncbi request reprint Differences in cognitive factors between "true drug" versus "placebo pattern" response to fluoxetine as defined by pattern analysis
    Amy H Farabaugh
    Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, USA USA
    Hum Psychopharmacol 21:221-5. 2006
    ..This study examines the relationship between cognitive factors and TDR and PPR to fluoxetine...
  6. pmc Assessing depression and factors possibly associated with depression during the course of Parkinson's disease
    Amy H Farabaugh
    Depression Clinical and Research Program, Massachusetts General Hospital, 1 Bowdoin Square, Boston, MA 02114, USA
    Ann Clin Psychiatry 23:171-7. 2011
    ..We wanted to examine the prevalence of dPD using different definitions of depression, as well as examine factors associated with dPD...
  7. ncbi request reprint Predictors of stable personality disorder diagnoses in outpatients with remitted depression
    Amy Farabaugh
    Depression and Clinical Research Program, Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA
    J Nerv Ment Dis 190:248-56. 2002
    ....
  8. ncbi request reprint Relationships between major depressive disorder and comorbid anxiety and personality disorders
    Amy Farabaugh
    Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Compr Psychiatry 46:266-71. 2005
    ....
  9. pmc Pattern of depressive symptoms in Parkinson's disease
    Amy H Farabaugh
    Massachusetts General Hospital, Boston, MA 02114, USA
    Psychosomatics 50:448-54. 2009
    ..Depressive symptoms are common in Parkinson's disease (PD); however, it is unclear whether there are specific depressive symptom patterns in patients with PD and comorbid depression (dPD)...
  10. ncbi request reprint The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients
    Amy Farabaugh
    Depression Clinical and Research Program, Massachusetts General Hospital, MA WAC 812, USA
    Int Clin Psychopharmacol 20:87-91. 2005
    ..In conclusion, the presence of early improvement on the HAMD-17 item concerning fatigue and general somatic symptoms is significantly predictive of achieving remission at endpoint with active study treatment but not with placebo...
  11. ncbi request reprint The overlap between personality disorders and major depressive disorder (MDD)
    Amy Farabaugh
    The Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Ann Clin Psychiatry 16:217-24. 2004
    ..Research studies have focused attention on the importance of the comorbidity of personality disorders and depression...
  12. ncbi request reprint The potential relationship between levels of perceived stress and subtypes of major depressive disorder (MDD)
    A H Farabaugh
    Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA WAC 812, USA
    Acta Psychiatr Scand 110:465-70. 2004
    ....
  13. ncbi request reprint Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trial
    Shamsah B Sonawalla
    Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, WACC 812, 15 Parkman Street Boston, MA 02114, USA
    Prog Neuropsychopharmacol Biol Psychiatry 26:1415-9. 2002
    ..The purpose of this study was to assess the differences between early (EDs), late drop-outs (LDs) and completers in the continuation phase of a clinical trial...
  14. pmc Compulsive use of alcohol among college students
    Paola Pedrelli
    Depression Clinical and Research Program, Massachusetts General Hospital, 1 Bowdoin Square, 6th Floor, Boston, MA 02114, USA
    Psychiatry Res 205:95-102. 2013
    ..This study suggest that the CHQ compulsive use of alcohol item should not be used as a stand-alone screening for alcohol or drug problems but it could be considered a marker for at-risk behaviors...
  15. doi request reprint Gender, depressive symptoms and patterns of alcohol use among college students
    Paola Pedrelli
    Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Psychopathology 44:27-33. 2011
    ..The current study extends previous research by investigating the relationship between depressive symptoms, daily alcohol use and compulsive drinking among college students and whether gender moderates these relationships...
  16. doi request reprint Compulsive alcohol use and other high-risk behaviors among college students
    Paola Pedrelli
    Depression and Clinical Research Program, Massachusetts General Hospital, Boston, USA
    Am J Addict 20:14-20. 2011
    ..The high co-occurrence of compulsive drinking, illicit substances, compulsive sexual activities, and gambling in college students suggests the need for comprehensive programs addressing high-risk behaviors together...
  17. doi request reprint Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment
    David Mischoulon
    Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA 02114, USA
    CNS Spectr 17:76-86. 2012
    ..To examine the prevalence of the C677T polymorphism of the methylene tetrahydrofolate reductase (MTHFR) gene and the A2756G polymorphism of methionine synthase (MS), and their impact on antidepressant response...
  18. pmc Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI
    Stella Bitran
    Department of Psychiatry, Depression Clinical and Research Program, Massachusetts General Hospital, Boston, USA
    Int Clin Psychopharmacol 26:206-12. 2011
    ..Early scrutiny of the Hamilton Depression Rating Scale-17 anxiety/somatization items may help to predict remission of major depressive disorder...
  19. pmc Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome
    Amy H Farabaugh
    Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Int Clin Psychopharmacol 25:214-7. 2010
    ..Future studies are warranted to further investigate this relationship as well as that between anxious depression and treatment outcome...
  20. ncbi request reprint Psychiatric comorbidity as a predictor of clinical response to nortriptyline in treatment-resistant major depressive disorder
    George I Papakostas
    Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, Mass 02114, USA
    J Clin Psychiatry 64:1357-61. 2003
    ..The purpose of this study was to test whether the presence of comorbid Axis I and Axis II disorders predicts clinical response to an open trial of nor-triptyline among patients with treatment-resistant depression...
  21. pmc A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder
    David Mischoulon
    Massachusetts General Hospital, Depression Clinical and Research Program, Boston, MA 02114, USA
    J Clin Psychiatry 70:1636-44. 2009
    ..To examine the efficacy and tolerability of ethyl-eicosapentaenoate (EPA-E) monotherapy for major depressive disorder (MDD)...
  22. ncbi request reprint Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report
    Madhukar H Trivedi
    Department of Psychiatry, University of Texas UT Southwestern Medical Center, Dallas 75390 9119, and the Clinical Psychopharmacology Unit, Massachusetts General Hospital, Boston, USA
    J Clin Psychiatry 67:185-95. 2006
    ..The aim of this study was to examine sociodemographic and clinical correlates of HRQOL in a large cohort of outpatients with MDD...
  23. ncbi request reprint Tridimensional personality questionnaire factors in major depressive disorder: relationship to anxiety disorder comorbidity and age of onset
    Dost Ongur
    Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, WACC 812, Boston, MA 02114, USA
    Psychother Psychosom 74:173-8. 2005
    ..We used the Tridimensional Personality Questionnaire (TPQ) to study the relationship between temperamental traits and comorbid anxiety disorders as well as age of onset of major depressive disorder (MDD) in 263 patients with MDD...
  24. doi request reprint The absence of depressive symptoms is not the presence of wellness: validation of the Clinical Positive Affect Scale
    Andrew A Nierenberg
    Bipolar Clinic and Research Program, Massachusetts General Hospital, Boston, MA 02114, USA
    Aust N Z J Psychiatry 46:1165-72. 2012
    ..Currently, no clinically useful scale has been developed to measure positive affect. To fill this gap, we developed the Clinical Positive Affect Scale (CPAS)...
  25. ncbi request reprint Personality disorders and the trimensional personality questionnaire factors in major depressive disorder
    Amy Farabaugh
    Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    J Nerv Ment Dis 193:747-50. 2005
    ..Certain temperament traits, especially HA and NS, appear to be associated with specific patterns of personality clusters among depressed patients...
  26. ncbi request reprint Gender differences in depression: findings from the STAR*D study
    Sheila M Marcus
    Department of Psychiatry, University of Michigan Medical School, 2101 Commonwealth Blvd Suite B, Ann Arbor, MI 48105, USA
    J Affect Disord 87:141-50. 2005
    ..The STAR*D (Sequenced Treatment Alternatives to Relieve Depression) multicenter trial provides a unique opportunity to explore gender differences in outpatients with nonpsychotic MDD...
  27. pmc Personality disorders and perceived stress in major depressive disorder
    Michele Candrian
    Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, 15 Parkman Street, Boston, MA 02114, USA
    Psychiatry Res 160:184-91. 2008
    ....
  28. ncbi request reprint Fluoxetine treatment of depressed patients with comorbid anxiety disorders
    Shamsah B Sonawalla
    Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA
    J Psychopharmacol 16:215-9. 2002
    ..Further double-blind, placebo-controlled trials are required in larger samples to confirm our findings...
  29. ncbi request reprint Enrolling research subjects from clinical practice: ethical and procedural issues in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial
    Jonathan E Alpert
    Massachusetts General Hospital, Depression Clinical and Research Program, 50 Staniford Street, 4th Floor, Boston, 02114, USA
    Psychiatry Res 141:193-200. 2006
    ....
  30. ncbi request reprint Problem-solving ability and comorbid personality disorders in depressed outpatients
    Rebecca Harley
    Depression Clinical and Research Program, Massachusetts General Hospital, 15 Parkman Street, Boston, MA 02114, USA
    Depress Anxiety 23:496-501. 2006
    ..Treatment with fluoxetine is less likely to lead to remission of MDD in patients with stable PDs. More study is needed to investigate causal links between PDs, problem solving, and MDD treatment response...
  31. ncbi request reprint Perceived stress and cognitive vulnerability mediate the effects of personality disorder comorbidity on treatment outcome in major depressive disorder: a path analysis study
    Michele Candrian
    Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    J Nerv Ment Dis 195:729-37. 2007
    ..Depressogenic cognitions might be continuously activated by chronic distress in MDD subjects reporting axis II pathology, leading to stress exacerbation and eventually poorer treatment outcome...
  32. ncbi request reprint Early improvements in anxiety, depression, and anger/hostility symptoms and response to antidepressant treatment
    Amy Farabaugh
    Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA USA
    Ann Clin Psychiatry 22:166-71. 2010
    ....
  33. doi request reprint A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction
    Christina M Dording
    Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA
    CNS Neurosci Ther 14:182-91. 2008
    ..Maca was well tolerated. Maca root may alleviate SSRI-induced sexual dysfunction, and there may be a dose-related effect. Maca may also have a beneficial effect on libido...
  34. pmc A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders
    A Eden Evins
    Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    J Clin Psychopharmacol 28:660-6. 2008
    ..Given the high abstinence rate achieved with CBT plus NRT, a ceiling effect related to the high level of intervention received by all subjects may have prevented an adequate test of bupropion...
  35. ncbi request reprint Health-related quality of life in depression: a STAR*D report
    Ella J Daly
    Department of Psychiatry, University of Texas Southwestern Medical School at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 9119, USA
    Ann Clin Psychiatry 22:43-55. 2010
    ..This report examined the psychological, physical, and social domains in a large sample of outpatients who entered the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial...
  36. ncbi request reprint Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trial
    Shamsah B Sonawalla
    Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston 20114, USA
    Prog Neuropsychopharmacol Biol Psychiatry 26:415-9. 2002
    ..The purpose of this study was to assess the differences between early and late drop-outs and completers in the continuation phase of a clinical trial...

Research Grants2